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Great saphenous vein stripping with preservation
of sapheno-femoral confluence: Hemodynamic
and clinical results
Paul Pittaluga, MD,a Sylvain Chastanet, MD,a and Jean-Jérôme Guex, MD,b Nice, France
Background: Radiofrequency and laser vein treatment, which entail preservation of the saphenous confluence, have called
into question the dogma of ligation of all tributaries at the sapheno-femoral confluence (SFC), so called “crossectomy”.
Nevertheless, crossectomy is still done when saphenous vein stripping is chosen for varicose vein treatment. The purpose
of this study was to evaluate results after stripping procedures in which the SFC was preserved.
Methods: This was a retrospective cohort study for which limbs treated for varicose veins by surgical stripping of the great
saphenous vein and preservation of the SFC were studied. All limbs had a preoperative duplex examination and showed
SFC and truncal incompetence of the great saphenous vein. Periodic postoperative standing duplex ultrasound and
clinical examinations were carried out, and results were recorded and analyzed retrospectively.
Results: A total of 195 lower limbs were operated on in 151 patients (128 women and 25 men) aged from 22 to 88 years
(mean age 56.8). The preoperative diameter of the SFC ranged from 4.7 to 17 mm (mean 9.5 mm). The preoperative
CEAP class distribution was C1 1.5%, C2 82.1%, C3 6.7%, and C4-C6 9.7%. Preoperative symptoms were present
in 61.8% of cases. Postoperative thrombosis of the SFC was observed in one case with an extension to the deep femoral
vein and pulmonary embolization at 1 month. Recovery was complete. At a mean of 24.4 months postoperatively (median
27.3 months, range 8 to 34.8), persistent SFC reflux was observed in only two cases (1.8%) and a SFC neovascularization
in one case (0.9%). Recurrence of varicose veins appeared in seven cases (6.3%) but in conjunction with SFC reflux in only
one case. Post treatment 83.9% of limbs were converted to CEAP clinical class 0 to 1 and significant symptom
improvement was observed in 91.3% of cases with an aesthetic benefit in 95.5%.
Conclusion: Preservation of the SFC during saphenous stripping gave good results with regard to hemodynamics and
neovascularization on the SFC, varicose vein recurrence, improvement of symptoms, and aesthetic appearance for legs
with a median follow-up of 27.3 months. ( J Vasc Surg 2008;47:1300-5.)It has been established that in cases of great saphenous
vein (GSV) reflux, the ostial valve is often continent. In the
literature The frequency of sub-ostial or more distal trunk
reflux was evaluated at around 50%.1-6 Endovenous treat-
ments for GSV reflux have called into question the principle
of ligation of all tributaries at the sapheno-femoral conflu-
ence, so called “crossectomy”, leaving the sapheno-femoral
confluence (SFC) in place upstream of the preostial
valve.7,8 Results of endovenous techniques show that SFC
reflux frequency in the medium term does not exceed 15%,
with anterograde drainage of the SFC collaterals towards
the femoral vein in 85% to 100% of cases.9-11
However, when surgical ablation of the GSV is per-
formed by means of stripping, crossectomy is still the norm.
Given the results of endovenous treatments since October
2003, we have no longer performed crossectomies during
surgical stripping of the GSV, including cases of ostial
reflux. The aim of this study is to evaluate the hemody-
namic and clinical results of this new approach.
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1300METHODS
Data studied. This was a retrospective cohort study
for which we reviewed all the files for patients who had
had a GSV stripping since October 2003. The preoper-
ative clinical and hemodynamic data were gathered, as
was information collected during the patient follow-up
period.
At each appointment, we classified signs according to
CEAP class and looked for symptoms suggesting chronic
venous insufficiency (CVI), such as pain, heaviness, weight-
iness, restless leg syndrome, nocturnal cramps, pruritus,
edema, and phlebalgia.
On the eighth postoperative day, we assessed analgesic
use and measured the surface area of ecchymoses (bruising)
and hematomas (solid swelling of clotted blood within the
tissues). This evaluation was done by a transfer paper on
which were drawn the apparent ecchymosis and the palpa-
ble hematomas, and then reported it on a cross-section
paper for measurement.
An echo-Doppler examination was systematically per-
formed before surgery and during the follow-up period
(after 1 month and 6 months, and then once a year). We
identified GSV reflux by a venous flushing maneuver with
manual compression and release of the calf muscles, and
SFC reflux by the Valsalva maneuver, both in standing
position. We considered reflux to be pathological if it lasted
for longer than 0.5 seconds.
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 6 Pittaluga et al 1301Exclusion criteria. We excluded files without a de-
tailed echo-Doppler examination or operation report. We
also excluded cases where a crossectomy had been associ-
ated with GSV stripping.
Statistical analysis. The qualitative bivariate compar-
isons were tested using the 2 test, and the mean compar-
isons were tested using the Student t test (paired t test). A
significance level of 0.05 was chosen for each comparison.
RESULTS
Population studied. Between October 2003 and
June 2006, we operated on 975 lower limbs (LL) to treat
varices with GSV reflux, including 220 GSV strippings.
Among this 220 GSV strippings, 10 crossectomies have
been carried out because of a large diameter of the SFC
(20 mm) or the presence of a thrombus in the SFC, and
15 strippings with preservation of the SFC were excluded
because of a lack of data. Thus, 195 strippings with preser-
vation of the SFC were studied. These operations involved
151 patients (126 women and 51 men) with a mean age of
59.8 (median 57, range 22 to 88 years).
The preoperative spread of these 195 LL over class C of
the CEAP classification was as follows: 3 LL were classed as
C0 or C1 (1.5%); 160 LL were classed as C2 (82.1%); 13
LLwere classed as C3 (6.7%); and 19 LLwere classed as C4
to C6 (9.7%). A total of 157 patients (80.5%) presented
symptoms that suggested CVI, whilst 38 patients (19.5%)
were asymptomatic.
Preoperative echo-Doppler examinations showed GSV
reflux in all cases (Table I), with an incontinent ostial valve
in 157 cases (80.5%), whereas 38 cases (19.5%) presented
subostial reflux. The mean preoperative diameter of the
SFC was 9.5 mm (median 9, range 5 to 17 mm).
Operations performed. We performed a ligature of
the GSV using a short inguinal approach, upstream of the
last descending collateral of the arch (Fig 1), which in the
vast majority of cases, was identified as the anterior collat-
eral of the GSV in the thigh (193 times out of 195). We
performed stripping according to the extension of the
saphenous reflux: long stripping up until the internal mal-
leolus in 87 cases (44.6%) and a short stripping below the
knee (superior third of the leg) in the remaining cases. The
mean number of phlebectomies was 39.7 (median 38,
range 0 to 87) according to the Muller’s technique12 for a
mean operation time of 79.2 minutes (median 85, range 30
to 125 minutes). All of the operations were unilateral and
carried out under tumescent local anesthesia. The mean
hospitalization period was 4 hours, and 194 times out 195,
Table I. Preoperative competence of the ostial valve at the
sapheno-femoral junction (SFJ) assessed by duplex scan
Competent ostial valve 38 19.5%
Incompetent ostial valve 157 80.5%
Total 195 100%
Mean diameter of SFJ (mm) 9.5 (5-17)surgery was carried out in ambulatory procedure. A preven-tative dose of low molecular weight heparin (LMWH) was
given in 15 cases (7.7%).
Immediate follow-up (Table II). We followed up all
patients on the eighth postoperative day. We noted ecchy-
mosis on the operated LL in 101 cases (51.8%) with a mean
surface area of 9.15 cm2 (median 9.9 cm2, range 2 to 21
cm2), and hematomas in 23 cases (7.6%) with a mean
surface area of 13.5 cm2. (median 10 cm2, range 2 to 55
cm2) In 119 cases (32.2%), patients did not take any
analgesics during this period. We prescribed time off work
in 71 cases for a mean duration of 4.5 days.
We did not find any significant difference in terms of
surface of ecchymosis and hematomas, and analgesics tak-
ing between the group of patient underwent short stripping
and the group who underwent long stripping.
We observed postoperative complications in two cases:
● Thrombosis of the SFC which had been left in place,
with extension to the femoral vein and a pulmonary
embolism diagnosed on D30 in a 37-year-old woman
with a SFC that was 16 mm in diameter. It was a
moderate pulmonary embolism requiring a 6-day stay
Fig 1. Traditional crossectomy (A) and ligation with preservation
of the sapheno femoral confluence (B).
Table II. Immediate postoperative follow-up after
stripping of the great saphenous vein without
crossectomy
Ecchymosis at D8 101 51.8%
Mean surface (cm2) 9.15
Hematoma at D8 23 11.8%
Mean surface (cm2) 13.5
Analgesic taking 76 38.9%
Mean taking (no of tablets) 3.2
Time off work prescription (number of patients) 71 58.7%
Mean time (no of days) 4.5in hospital with heparin treatment, followed immedi-
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months. Thrombophilia caused by a mutation of the
factor V Leiden gene was subsequently diagnosed. The
patient did not present any clinical or echo-Doppler
sequelae.
● A cutaneous infection of a micro-incision on the mid-
dle third of the leg.
We did not observe any other complications, particularly
inguinal complications.
Follow-up after 1 year. We followed up 112 out of
195 LL (57.4%) after the first postoperative year, with a
mean follow-up of 24.4 months (median 27.3, range 12 to
37 months). We evaluated all of the LL using an echo-
Doppler examination, and found SFC reflux in two cases
(1.8%) during the follow-up after one year (Fig 2). This
reflux was linked to inguinal neovascularization in one case,
and with reflux in the GSV anterior collateral in the thigh in
the other case. We observed one other case of inguinal
neovascularization which was not connected to SFC reflux
or to reflux in the underlying veins. The mean diameter of
the SFC was 5.4 mm (median 5.3, range 2.6 to 9.4 mm),
which is significantly lower than the mean preoperative
diameter for the 112 LL followed up (9.7 mm, P  .05).
From a clinical point of view, the CEAP classification
for the 112 LL followed up for more than a year was as
follows: C0-C1 in 94 cases (83.9%); C2 in 7 cases (6.3%);
C3 in 2 cases (1.8%); and C4 to C6 in 9 cases (8%) (Fig 3).
Furthermore, there was a very clear improvement or a
disappearance of symptoms in 63 out of 69 preoperative
symptomatic patients followed (91.3%) and an esthetic
improvement in 106 cases (94.6%).
We observed clinical varicose vein recurrence according
to the REVAS definition13 in seven cases (6.3%) during the
follow-up after 1 year (Fig 4): one case related to SFC reflux
through the anterior collateral of the GSV in the thigh
(diagnosed at 6 months postop); the six others were distal
recurrences that were not related to the SFC, neither to the
presence of an incompetent perforator vein.We treated two
of the recurrences with another phlebectomy without re-
Fig 2. Absence of reflux at the sapheno-femoral confluence.peated inguinal surgery (at 26 and 32 months), and threewith foam echosclerotherapy (at 25, 30, and 31 months).
The two remaining cases were not treated.
DISCUSSION
The population we operated on in this study presented
advanced varices, since they required GSV stripping. Only
20% of the varices we operated on during this period had
needed a GSV stripping. Furthermore, most of the patients
presented symptoms, and we observed SFC reflux in 80.5%
of the cases, whereas the rate is usually 50% in the literature
if there is saphenous reflux.1-6 In fact, the surgery we
performed was relatively extensive: long stripping in nearly
half the cases, with an average of 40 associated phlebecto-
mies and a mean operation duration of 80 minutes. Yet, in
our study, we observed no reflux in the preserved SFC in
98.2% of cases with a mean follow-up period of 24.4
months. These results are at least comparable or even
superior to the data published after 2 years of follow-up
after endovenous treatment using radiofrequency, where
reflux absence in the SFC varied between 80% and 90%.8-11
With the same follow-up period of 2 years, publications
regarding endovenous laser treatment show that there is no
SFC reflux in 93% to 97% of cases.14,15 In view of these
Fig 3. Pre- and postoperative CEAP classification after great sa-
phenous vein stripping without crossectomy.
Fig 4. Absence of varicose vein recurrence.results, we can ask ourselves whether carrying out a surgical
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proves hemodynamics of the preserved SFC, given the fact
that the GSV cannot become permeable again and perhaps
especially given the ablation of the varicose reservoir by the
absence of an outflow for the reflux. In our series, one of
the two persistent SFC reflux cases was linked to insuffi-
ciency of the GSV anterior collateral, which appeared early
and was probably linked to insufficient excision of the crural
varices. The hemodynamic benefits of ablation of the vari-
cose reservoir are mentioned in the literature.16 However,
certain publications 17,18 show that varices treatment does
not affect the result once endovenous treatment of the GSV
has been performed, but these series only have a short
follow-up period and include a large number of secondary
procedures aimed at treating the varicose reservoir.
Despite an inguinal approach, the rate of inguinal neo-
vascularization after 2 years was very low in our series (1.8%
at 2 years). This figure is not higher than the figures
recorded after endovenous treatment where the neovascu-
larization rate varies from 0% to 2.8%,8-11 and it is much
lower than traditional surgical series including enlarged
crossectomy with rates of 20% to 53%.19,20-22 It seems that
preserving the superficial abdominal and perineal venous
drainage by not dissecting the SFC and by not dividing the
collaterals, enables neovascularization to be avoided. Using
a limited inguinal approach without dissecting the SFC
does not, therefore, seem to cause more neovascularization
since it does not prevent the SFC collaterals from draining
into the femoral vein.
The clinical recurrence rate that we observed (6.3%)
can be compared with series of strippings associated with
traditional enlarged crossectomies where the figures varied
from 10% to 25% after 2 years.19,22 Our recurrence rate is
also better than that observed after endovenous treatment
with an identical follow-up period where there is a 12% to
15% clinical recurrence rate.9-11 It is difficult to compare
the different series, because the extent of the preoperative
varices and the extent of the varicose reservoir resection
are never mentioned. However, these elements are prob-
ably determining factors in recurrence after a first line
therapy treatment. Moreover, in our study, clinical re-
currence was independent of SFC reflux in six cases out
of seven, just as the ablation of the saphenous vein did
not present recurrence in the series of endovenous treat-
ments.9-11 These observations support the theory that
varicose disease develops from the superficial distal ve-
nous network, which is increasing mentioned in the
literature,3-6,23 contrary to the traditional description
whereby varicose disease develops downwards from the
saphenous confluences and veins.24,25
The follow-up to our surgical series was uneventful,
both in terms of ecchymoses (none in 48.2% of cases) and
hematomas (none in 88.2% of cases), and in terms of
postoperative pain (no analgesics taken in 68.1% of cases)
and time off work (4.5 days on average). These data are
similar to those published after endovenous treatment.26,27
We have already reported the benefits of tumescent local
anesthesia and immediate walking after varicose vein sur-gery.28 Obviously, prospective randomized studies would
be required to compare postoperative quality of life after
surgical saphenous ablation under tumescent local anesthe-
sia and after endovenous procedures.
However, we did observe a serious postoperative com-
plication with SFC thrombosis, complicated by an exten-
sion to the femoral vein and by a pulmonary embolism. SFC
thrombosis with extension of the thrombus to the femoral
vein has been reported in the literature after endovenous
treatment.9,29,30 This potentially serious complication
risk should probably be taken into account when preserv-
ing the SFC by means of targeted prevention, for exam-
ple using LMWH treatment or a traditional enlarged
crossectomy in cases of thrombophilia, history of throm-
bosis, or very dilated SFC (20 mm). An early postop-
erative echo-Doppler examination (eg, after 24 to 48
hours) could also be recommended in order to detect
thrombo-embolic complications.31
It seems that preserving the SFC during GSV reflux
treatment is really worthwhile due to the preservation of
inguinal venous drainage. Furthermore, surgical treatment
can remain competitive compared with endovenous tech-
niques if the surgery is mini-invasive and carried out under
tumescent local anesthesia with immediate walking. This is
particularly true if the GSV treatment also includes excision
of widespread varices, as the benefits of endovenous treat-
ment (which is, by definition, limited to the saphenous
veins) are debatable.
CONCLUSION
As for endovenous treatments, conserving the SFC
seems to be beneficial during surgical ablation of the saphe-
nous vein, because the physiological venous drainage of the
inguinal region is preserved, including a low level of neo-
vascularization on the groin and varicose recurrence for legs
with a median follow-up of 27.3 months. Furthermore,
surgical ablation can remain competitive compared with
endovenous treatments in terms of the simplicity of the
surgical outcome, if it is performed under tumescent local
anesthesia with immediate walking, particularly in cases of
extensive varices. Further studies are needed in order to
assess the postoperative risk of SFC thrombosis and the
long-term hemodynamic results of both this surgical ap-
proach and of endovenous techniques.
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This study is inspired by the findings following endovenous
ablation of the great saphenous vein (GSV), which has shown
that there is no disadvantage leaving a longer GSV stump and
tributaries draining the abdominal wall intact. It may even be
preferable to do so, since neovascularization at the groin level
rarely occurs with this procedure. In this report, the routine
surgical flush ligation has, therefore, been replaced by a lower
ligation placed above the highest descending branch leaving a
remnant of the GSV. The authors assume that it is the placement
of the tie rather than the surgical trauma in itself, which is thesafe, gives symptom relief, and results in a good aesthetic result
in the short term, but that is, however, true for most interven-
tions on the GSV. The observation period is too short to assess
the important end points, ie, avoidance of neovascularization
and late recurrence of varicosities. Ultimately, only a random-
ized study can validate this concept.
I have some methodological concerns regarding adherence to
reporting standards. The way the CEAP classification was origi-
nally constructed prohibits the use of the C-class for serial evalua-
tion, and it must not be used for this purpose. Several other scores,
eg, Venous Clinical Severity Score (VCSS), quality of life scores,
